PTON vs RXRX
Peloton Interactive Inc (PTON) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Peloton Interactive Inc (PTON) is a leisure company listed on NASDAQ.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported PTON revenue for 2025-06-30 was $2.49B. Net income was -$118.9M. Revenue was down 7.8% from 2024-06-30 to 2025-06-30. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
PTON currently screens at market cap $2.39B and trailing P/E 92.2. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the PTON and RXRX stock pages for the full models.
Not investment advice.